Erratum: Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT (Bone Marrow Transplantation, (2017), 52, 2, (209-215), 10.1038/bmt.2016.266)

M. Robin, R. Porcher, W. Zinke-Cerwenka, A. van Biezen, L. Volin, G. Mufti, C. Craddock, J. Finke, C. Richard, J. Passweg, A. Peniket, J. Maertens, G. Sucak, T. Gedde-Dahl, A. Vitek, A. Nagler, D. Blaise, D. Beelen, N. Maillard, R. SchwerdtfegerT. de Witte, N. Kroger

Research output: Contribution to journalComment/debate

Abstract

Correction to: Bone Marrow Transplantation (2016) 52, 209–215; doi:10.1038/bmt.2016.266; published online 7 November 2016 Since the publication of this article, it has been noted that an acknowledgement was inadvertently not included in the paper. The acknowledgement is now given here: AP acknowledges funding from The Haematology and Stem Cell Theme of the Oxford Biomedical Research Centre (BRC).

Original languageEnglish
Pages (from-to)1081
Number of pages1
JournalBone Marrow Transplantation
Volume52
Issue number7
DOIs
StatePublished - Jul 2017

Funding

FundersFunder number
Haematology and Stem Cell Theme of the Oxford Biomedical Research Centre
NIHR Imperial Biomedical Research Centre

    Fingerprint

    Dive into the research topics of 'Erratum: Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT (Bone Marrow Transplantation, (2017), 52, 2, (209-215), 10.1038/bmt.2016.266)'. Together they form a unique fingerprint.

    Cite this